Regeneron Pharmaceuticals SG&A Expense (TTM) Trends | YCharts

Regeneron Pharmaceuticals, Inc. (REGN)

827.72 -15.75 (-1.87%) USD | NASDAQ | Sep 04, 16:00

828.01 +0.29 (+0.04%) After-Hours: 20:00

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for REGN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (TTM) Chart

Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.

Date	Value
June 30, 2026	2.743B
March 31, 2026	2.715B
December 31, 2025	2.70B
September 30, 2025	2.717B
June 30, 2025	2.774B
March 31, 2025	2.898B
December 31, 2024	2.954B
September 30, 2024	2.900B
June 30, 2024	2.826B
March 31, 2024	2.719B
December 31, 2023	2.631B
September 30, 2023	2.554B
June 30, 2023	2.443B
March 31, 2023	2.267B
December 31, 2022	2.116B
September 30, 2022	2.015B
June 30, 2022	1.931B
March 31, 2022	1.869B
December 31, 2021	1.825B
September 30, 2021	1.569B
June 30, 2021	1.451B
March 31, 2021	1.384B
December 31, 2020	1.346B
September 30, 2020	1.494B
June 30, 2020	1.472B

Date	Value
March 31, 2020	1.418B
December 31, 2019	1.342B
September 30, 2019	1.381B
June 30, 2019	1.446B
March 31, 2019	1.517B
December 31, 2018	1.556B
September 30, 2018	1.475B
June 30, 2018	1.412B
March 31, 2018	1.354B
December 31, 2017	1.320B
September 30, 2017	1.236B
June 30, 2017	1.200B
March 31, 2017	1.185B
December 31, 2016	1.178B
September 30, 2016	1.147B
June 30, 2016	1.087B
March 31, 2016	969.21M
December 31, 2015	838.53M
September 30, 2015	687.32M
June 30, 2015	627.07M
March 31, 2015	554.90M
December 31, 2014	504.76M
September 30, 2014	443.10M
June 30, 2014	390.96M
March 31, 2014	361.00M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years

Start Trial

--

Minimum

--

Maximum

--

Average

--

Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks

Start Trial

Alnylam Pharmaceuticals, Inc.	1.318B
AbbVie, Inc.	14.67B
Gilead Sciences, Inc.	9.147B
Amgen, Inc.	7.019B
Biogen, Inc.	2.594B